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Fluprostenol-Induced MAPK Signaling Is Independent of Aging
in Fischer 344/NNiaHSd x Brown Norway/BiNia Rat Aorta

Kevin M. Rice,1,2,3,4 Ernest M. Walker,5 Sunil K Kakarla,3,4,6 Satyanarayana Paturi,1,3,4
Miaozong Wu,1,3 Sumit Narula,4 and Eric R. Blough1,2,3,4,6
1Department of Biological Sciences, 2Department of Exercise Science, Sport and Recreation, 3Cell
Differentiation and Development Center, 4Laboratory of Molecular Physiology, 5Department of Anatomy
and Pathology, and 6Department of Pharmacology, Physiology, and Toxicology, Marshall University,
Huntington, West Virginia
Abstract. The factors that regulate vascular mechanotransduction and how this process may be altered
with aging are poorly understood and have not been widely studied. Recent data suggest that increased
tissue loading can result in the release of prostaglandin F2 alpha (PGF2α) and other reports indicate that
aging diminishes the ability of the aged aorta to activate mitogen activated protein kinase (MAPK) signaling
in response to increased loading. Using ex vivo incubations, here we investigate whether aging affects the
ability of the aorta to induce phosphorylation of extracellular signal-regulated kinase 1/2 (ERK½-MAPK),
p38-MAPK, and Jun N-terminal kinase (JNK-MAPK) activation following stimulation with a PGF2α
analog, fluprostenol. Compared to aortas from 6-mo animals, the amounts of ERK½- and p38-MAPK
remained unchanged with aging, while the level of JNK-MAPK protein increased by 135% and 100% at
30- and 36-mo, respectively. Aging increased the basal phosphorylation of ERK½ (115% and 47%) and
JNK (29% and 69%) (p <0.05) in 30- and 36-mo aortas, while p38 phosphorylation levels remained
unaltered. Compared to age-matched controls, fluprostenol induced phosphorylation of ERK½ (310%,
286%, and 554%), p38-MAPK (unchanged, 48%, and 148%), and JNK (78%, 88%, and 95%) in 6-, 30and 36-mo aortas, respectively. These findings suggest that aging does not affect the ability of the rat aorta
to activate ERK½-, p38-MAPK, and JNK-MAPK phosphorylation in response to PGF2α stimulation.
Keywords: aorta, fluprostenol, ERK½, p38-MAPK, JNK, aging
Introduction
Aging is the primary risk factor for cardiovascular
disease (CVD). Although not well understood, it is
thought that this increased risk may be due to ageassociated changes in cardiovascular structure and
function. Recently we reported that stretching of
aortic vascular smooth muscle cells (VSMC)
activates mitogen activated protein kinase (MAPK)
signaling and that this response is altered with
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aging in Fischer 344/NNiaHSd x Brown Norway
/BiNia rat (F344BN) aortas [1]. Specifically, we
demonstrated that aging is associated with decreased
ability of the aged aorta to activate p38-MAPK and
c-Jun N-terminal kinase (JNK) signaling. The
factors that regulate load-induced signaling in the
aorta and other tissues are not well understood. In
addition to mechanical stimuli, the possibility
exists that autocrine and paracrine factors may play
roles [2,3]. For example, Vandenburgh et al. [4]
demonstrated that mechanical stimulation of
cultured skeletal muscle increases the synthesis of
prostaglandin F2 alpha (PGF2α) and that this
increase is associated with the regulation of protein
turnover and muscle cell growth. Similarly, it has
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recently been shown that PGF2α can induce
hypertrophy of neonatal rat ventricular myocytes
and VSMC in vitro [5-8]. Whether the differences
in mechanically-induced signaling that we observed
in the aging F344BN aorta are due to alterations in
the ability of the aged aorta to respond to PGF2α
is unknown.
PGF2α receptor stimulation has been shown
to induce MAPK activation in human endometrium
epithelial cells [9] and cardiac myocytes [7]. The
MAPK signaling network is composed of three
homologous yet distinct kinase cascade pathways
including the extracellular signal-regulated kinases
(ERK)½, c-Jun NH2-terminal kinase (JNK), and
p38 kinase [10]. Studies in rats and humans have
implicated the activation (phosphorylation) of
MAPK signaling in the regulation of protein
synthesis, mRNA stability, as mediators of apoptosis
and the inflammatory response, and as key players
in the control of load-induced alterations in protein
expression [11-14]. Whether aging affects the ability
of VSMC to activate MAPK signaling in response
to PGF2α stimulation is not well understood.
Here we investigate if aging affects the ability
of the aorta to respond to PGF2α by subjecting
isolated aortas to a PGF2α analog, fluprostenol
(FP). Our data demonstrate that fluprostenol
activates ERK½, JNK, and p38-MAPK in aorta,
and that fluprostenol-induced phosphorylation of
MAPKs increases with aging. The data suggest that
stretch-induced MAPK activation in the aging
aorta is not associated with an inability of the aged
aorta to respond to PGF2α.

older rats exhibited signs of failure to thrive, such as precipitous
weight loss, disinterest in the environment, or unexpected
gait alterations.

Materials and Methods

Immunoblotting. Samples were pulverized with liquid
nitrogen and lysed on ice for 30 min in T-PER (2 ml/g tissue)
(Pierce, Rockford, IL) supplemented with 100 mM NaF, 1
mM Na 3VO4, 2 mM PMSF, 1 μg/ml aprotinin, 1 μg/ml
leupeptin, and 1 μg/ml pepsatin. After lysis, homogenates
were centrifuged 10 min at 10,000 rpm and the supernatants
collected. Protein concentrations of the supernates were
determined in triplicate using the Bradford method (Pierce,
Rockford, IL) with bovine serum albumin as a standard.
Samples were diluted to a concentration of 1.5 mg/ml in SDS
loading buffer, boiled for 5 min, and 30 µg of protein was
analyzed using SDS-PAGE. Transfer of protein onto nitrocellulose membranes was performed using standard conditions
[9] and equal loading between lanes and membranes was
verified by staining the membranes with Ponceau S. For
immunodetection, membranes were blocked with a solution
of 5% nonfat dry milk prepared in Tris-buffered saline
containing 0.1% Tween 20 (TBST) for 1 hr at room

Animals. All procedures were in accordance with the Guide
for the Care and Use of Laboratory Animals as approved by
the Council of the American Physiological Society and the
Animal Use Review Board of Marshall University. All
procedures were in accordance with the Public Health Service
animal welfare policy. Adult (6-mo), aged (30-mo), and very
aged (36-mo) male Fischer 344 /NNiaHSd x Brown Norway
/BiNia (F344BN) rats were obtained from the National
Institute on Aging (NIA) and were barrier-housed (2 rats/
cage) in an AAALAC approved vivarium. Housing conditions
consisted of 12 hr/12 hr dark-light cycle and a room
temperature of 22 ± 2˚C. The rats were provided food and
water ad libitum. Rats were allowed to recover from shipment
for at least two weeks before experimentation, during which
time the rats were observed and weighed weekly. None of the

Materials. Antibodies against p38-MAPK (#9212), phosphop38-MAPK (Thr180/Tyr182) (p-p38-MAPK, #9216), extracellular-regulated kinase 1/2 (ERK1/2, #9102), phosphoERK1/2 (Thr202/Tyr204) (p-ERK1/2, #4377), c-Jun
N-terminal kinase 1/2 (JNK1/2, #9252), phospho-JNK1/2
(Thr183/Tyr185) (p-JNK1/2, #9251), mouse IgG (#7076),
and rabbit IgG (#7074) were from Cell Signaling Technology
(Beverly, MA). Precast 7.5%, 10%, and 15% SDS-PAGE gels
were from Cambrex Biosciences (Baltimore, MD). Enhanced
chemiluminescent (ECL) western blot detection reagent was
from Amersham Biosciences (Piscataway, NJ). Restore
western blot stripping buffer was from Pierce (Rockford, IL).
3T3 cell lysates were from Santa Cruz Biotechnology (Santa
Cruz, CA). Fluprostenol and all other chemicals were from
Sigma (St. Louis, MO).
Artery preparation and ex vivo incubations. Rats were
anesthetized with a ketamine-xylazine (4:1) cocktail (50 mg/
kg ip) and supplemented as necessary for reflexive response.
In a sterile, aseptic environment, the ventral surface of the
thorax was shaved and the superficial musculature was
exposed by means of a transverse incision through the skin
distal to the thoracic cavity. After midline laparotomy and
perforation of the heart, the aorta was isolated and removed
from the left ventricle to the renal arch. Isolated aortas were
cleansed of connective tissue, transected at the subclavian
artery and the diaphragmatic insertion, and cut longitudinally.
The vessel segment was denuded and allowed to equilibrate in
oxygenated Krebs-Ringer bicarbonate (KRB) buffer at 37˚C
for 1 hr. Vessels were incubated for 30 min with vehicle
(ethanol) or 1 µM fluprostenol, on the basis of a previous
finding that this concentration of fluprostenol is sufficient to
induce intracellular signaling and myocyte hypertrophy [7].
Following incubations, vessels were collected and snap frozen
in liquid nitrogen. All vessel handling was done in oxygenated
KRB buffer maintained at 37˚C.
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temperature and then incubated with the appropriate primary
antibody overnight. After washing in TBST, the membranes
were exposed to horseradish peroxidase-labeled (HRP) IgG
secondary antibody (1 hr at room temperature).
Protein bands were visualized with ECL (Amersham
Biosciences). Exposure time was adjusted to keep the
integrated optical densities (IODs) within a linear and nonsaturated range, and band signal intensity was quantified by
densitometry using a flatbed scanner (Epson Pefection 3200
PHOTO) and imaging software (AlphaEaseFC). Molecular
weight markers (Cell Signaling) were used as molecular mass
standards and NIH 3T3 cell lysates were included as positive
controls.
Data Analysis. Results are reported as mean ± SE. Data were
analyzed using SigmaStat 3.0. Multiple group comparisons
were performed by one-way ANOVA followed by StudentNewman-Keuls post hoc test to determine differences between
groups. The level of significance accepted was p <0.05.

Results
Aging effects on basal expression of JNK. To
determine whether aging influences the total
protein levels of ERK½-, p38-MAPK, and JNK
present in the aorta, immunoblot analyses were
performed using antibodies that recognize both
the unphosphorylated and phosphorylated forms
of the proteins. The Western blots failed to show
any significant changes in the expression of ERK½
and total p38-MAPK with aging (Fig. 1). Compared
to 6-mo animals, the amount of JNK was 135 ±
5% and 100 ± 6% higher in 30- and 36-mo aortas,
respectively (p <0.05).
Age-associated alterations of MAPK basal
phosphorylation in aorta. Because ERK½, JNK,
and p38-MAPK are thought to be regulated by
phosphorylation, it was of interest to determine if
the basal phosphorylation status of these proteins is
altered with aging. When compared to 6-mo aortas,
ERK½ phosphorylation was increased by 115 ± 5%
and 47 ± 8% at 30- and 36-mo, respectively (p
<0.05) (Fig. 2). JNK phosphorylation was increased
by 29 ± 9% and 70 ± 5% at 30- and 36-mo (p
<0.05) (Fig. 4). Conversely, basal phosphorylation
of p38-MAPK was unaltered with aging (Fig. 3).
Fluprostenol-induced MAPK phosphorylation in
aorta. PGF2α primarily mediates its cellular effects
by binding with high affinity (K i = 2.4 nM) to the
FP prostanoid receptor [10]. To investigate the

Fig. 1. Expression of ERK½, p38-MAPK, and JNK in aortas
from 6-mo (young adult), 30-mo (aged) and 36-mo (very
aged) Fischer 344/Brown Norway F1 hybrid rats. Relative
changes in protein levels were determined by immunoblotting.
The data are presented as fold-increase over the 6-mo value (n
= 4). An asterisk indicates significant difference from the
corresponding 6-mo value (p < 0.05).

Fig. 2. Basal (control) and fluprostenol-induced phosphorylation of ERK½ in aortas from 6-, 30- and 36-mo old rats.
Results were obtained by Western blot with immunodetection
of ERK½ phosphorylated at Thr202/Tyr204. An asterisk or
cross indicates significant difference from the control or the
corresponding 6-mo value, respectively (p < 0.05), n = 4.

Fluprostenol induces phosphorylation of MAPKS independent of aging

Fig. 3. Basal (control) and fluprostenol-induced phosphorylation of p38-MAPK in aortas from 6-, 30-, and 36-mo old
rats. Results were obtained by Western blot with immunodetection of p38 phosphorylated at Thr180/Tyr182. An
asterisk or cross indicates significant difference from the
control or the corresponding 6-mo value, respectively (p
<0.05), n = 4.

Fig. 4. Basal (control) and fluprostenol-induced phosphorylation of JNK-MAPK in aortas from 6-, 30- and 36-mo old
rats. Results were obtained by Western blot with immunodetection of JNK phosphorylated at Thr183/Tyr185. An
asterisk or cross indicates significant difference from the
control or the corresponding 6-mo value, respectively (p
<0.05), n = 4.
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signaling evoked by FP receptor activation we
stimulated rat aortic smooth muscle with the
PGF2α receptor agonist, fluprostenol. Fluprostenol
was chosen as an agonist because it has a similar
affinity for the fluprostenol receptor as PGF2α (K i
= 3.8 nM) but does not bind to other prostanoid
receptors. As shown in Figs. 2, 3, and 4, incubation
with fluprostenol increased phosphorylated levels
of MAPKs. Compared to unstimulated controls,
the phosphorylation of ERK½ was increased 310 ±
36%, 286 ± 51%, and 554 ± 38% at 6- , 30- and
36-mo, respectively (p <0.05) (Fig. 2). Similarly,
fluprostenol increased JNK phosphorylation by 78
± 4%, 88 ± 6%, and 95 ± 14% at 6-, 30- and 36mo, respectively (p <0.05) (Fig. 4). Conversely,
fluprostenol failed to affect p38-MAPKMAPK
phosphorylation in 6-mo animals (Fig. 3), while in
30- and 36-mo animals the stimulation increased
p38-MAPK phosphorylation by 48 ± 6% and 148
± 16% (p <0.05), respectively (Fig. 3).
Discussion
In adult tissues, the mechanisms regulating ERK½,
p38-MAPK, and JNK activation by mechanical
stress have been linked to stretch-induced release of
nitric oxide (NO), arachidonic acid metabolites,
and prostacyclin from the endothelial cells acting
upon the VSMC [15-17] as well as PDGF, fibroblast
growth factor, and ATP [18-23]. Previously we
demonstrated that an acute elevation in loading
pressure in vitro can increase the phosphorylation
status of ERK½, p38-MAPK, and JNK in aortas
of rats [1]. Importantly, we also demonstrated that
aging reduced the ability of the aorta to activate
p38-MAPK and JNK proteins. These data suggest
that aging alters the ability of the aorta to “sense”
and “respond” to mechanical stimuli.
One finding of the present study is that aging
appears to increase JNK expression in aorta (Fig.
1). A similar increase in the amount of JNK-MAPK
with aging was demonstrated previously in the
aging F344BN aorta [24]. It is unclear why aging
may increase the expression of JNK. It is thought
that the JNK is a “stress kinase” [25,26]. Recent
data suggest that aging may be associated with
increases in the amount of reactive oxygen species
(ROS) [24,27,28]. Whether this age-related increase
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in ROS is related to changes in JNK expression is
not known. JNK phosphorylates numerous proteins
that reside in mitochondria or act within nuclei.
This phosphorylation modifies the activity of these
proteins allowing JNK activity to regulate several
important cellular functions. Inflammatory signals,
changes in levels of ROS, ultraviolet radiation,
protein synthesis inhibitors, and a variety of stress
stimuli have been shown to activate JNK.
Muscle stretch or loading has been shown to
induce the release of PGF2α, which has a potential
to activate MAPK proteins [29]. Whether aging
affects the ability of the aorta to respond to PGF2α
and whether this effect, if present, could help to
explain differences in the ability of the aged aorta
to “respond” to increases in loading is unknown. In
the present study, we found that fluprostenol can
activate MAPK proteins in the intact rat aorta
(Figs. 2, 3, 4), which is consistent with previous
data using cultured VSMC cells [30,31] and other
work utilizing porcine carotid arteries [9].
The ability of fluprostenol-induced phosphorylation of MAPK proteins is retained in the aged
F344BN rat aortas. Compared to 6-mo rats, FPinduced phosphorylation of both the ERK½ and
JNK proteins in aged aorta was similar (Figs. 3, 4).
Nonetheless, it should be noted that age-associated
differences in the fluprostenol response appear to
exist. Whereas fluprostenol stimulation fails to
elicit phosphorylation of p38 in the 6-mo aortas, a
marked increase in the amount of p38-MAPK
phosphorylation was observed in 30- and 36-mo
aortas (Fig. 2). The mechanism of this age-related
difference in p38-MAPK activation is unknown.
In conclusion, our data suggest that aging does
not diminish the ability of the aorta to activate
MAPK proteins in response to fluprostenol
stimulation. This finding is consistent with the
possibility that age-related changes in the ability of
the aorta to undergo MAPK activation in response
to increased loading is not due to an inability of the
aged aorta to respond to PGF2α. Nonetheless, it
should be noted that it is not known if aging affects
the amount of PGF2α generated upon aortic
stretch. It is also unknown if aging alters PGF2α
receptor density. Perhaps age-related decreases in
PGF2α release or receptor density could help to
explain why aortic mechanotransduction may be

altered with aging. Further experiments will be
useful in addressing these limitations.
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